antibodies

Merck Acquires Chromatography Business from JSR Life Sciences

Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Download this complimentary Expert Insights eBook today!

Kyowa Kirin to Establish New Biologics Manufacturing Plant in US

Kyowa Kirin announced a new, state-of-the-art manufacturing facility in Sanford, North Carolina, US. Kyowa Kirin will invest up to $530 million (€489 million) in constructing a 15,951m2 two-bioreactor facility, scheduled to break ground in Q3 of 2024.

Shire Takes Novimmune’s Blood Therapy Rights

Glythera Launches ADC Project

AstraZeneca and Pieris Link on Respiratory Disease

Tusk in UK Cancer Collaboration

DSM to Fold Pharma Arm into Venture with Private Equity Firm

DSM, Recepta Announce Contract Manufacturing Agreement

DSM Biologics to Acquire Rhobust Technology from Upfront Chromatography